Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy

被引：33

作者：

Carasso, Shemy ^{[1
]}

Woo, Anna ^{[1
]}

Yang, Hua ^{[1
]}

Schwartz, Leonard ^{[1
]}

Vannan, Mani A. ^{[2
]}

Jamorski, Michal ^{[1
]}

Linghorne, Meredith ^{[1
]}

Wigle, E. Douglas ^{[1
]}

Rakowski, Harry ^{[1
]}

机构：

[1] Univ Toronto, Toronto Gen Hosp, Div Cardiol, Toronto, ON M5G 2N2, Canada

[2] Univ Calif Irvine, Irvine, CA USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY | 2008年 / 21卷 / 05期

关键词：

D O I：

10.1016/j.echo.2007.08.020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We hypothesized that the time course of left ventricular (LV) outflow tract gradient reduction during septal ethanol ablation for patients with symptomatic hypertrophic obstructive cardiomyopathy is related to changes in myocardial mechanics. A total of 21 patients with hypertrophic obstructive cardiomyopathy undergoing septal ethanol ablation were analyzed. LV outflow tract gradient decreased with septal balloon occlusion, further decreased postethanol injection, and partially rebounded at discharge (5-6 days postprocedure). During balloon occlusion longitudinal and circumferential strain significantly decreased in all analyzed segments, significantly improved with alcohol injection only at sites distant to infarction, and normalized at all segments except infarcted ones at discharge. LV twist significantly improved with ethanol injection and remained high at discharge. Myocardial mechanics suggest that the decrease in LV outflow tract gradient during septal ethanol ablation coincides with global LV dysfunction despite only local ischemia during septal balloon occlusion. Global dysfunction is transient and the gradient rebounds when dysfunction is limited to the basal septum.

引用

页码：493 / 499

页数：7

共 25 条

[1]

Bhagwandeen R, 2003, CAN J CARDIOL, V19, P912

[2] LEVELS OF T-LYMPHOCYTE SUBPOPULATIONS, INTERLEUKIN-1-BETA, AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN ACUTE MYOCARDIAL-INFARCTION [J].

BLUM, A ;

SCLAROVSKY, S ;

REHAVIA, E ;

SHOHAT, B .

AMERICAN HEART JOURNAL, 1994, 127 (05) :1226-1230

[3] Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy [J].

Chang, SM ;

Lakkis, NM ;

Franklin, J ;

Spencer, WH ;

Nagueh, SF .

CIRCULATION, 2004, 109 (07) :824-827

[4]

D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031

[5] NEGATIVE INOTROPIC EFFECTS OF CYTOKINES ON THE HEART MEDIATED BY NITRIC-OXIDE [J].

FINKEL, MS ;

ODDIS, CV ;

JACOB, TD ;

WATKINS, SC ;

HATTLER, BG ;

SIMMONS, RL .

SCIENCE, 1992, 257 (5068) :387-389

[6] Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy [J].

Flores-Ramirez, R ;

Lakkis, NM ;

Middleton, KJ ;

Killip, D ;

Spencer, WH ;

Nagueh, SF .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :208-214

[7] New noninvasive method for assessment of left ventricular rotation - Speckle tracking echocardiography [J].

Helle-Valle, T ;

Crosby, J ;

Edvardsen, T ;

Lyseggen, E ;

Amundsen, BH ;

Smith, HJ ;

Rosen, BD ;

Lima, JAC ;

Torp, H ;

Ihlen, H ;

Smiseth, OA .

CIRCULATION, 2005, 112 (20) :3149-3156

[8] Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology [J].

Lang, RM ;

Bierig, M ;

Devereux, RB ;

Flachskampf, FA ;

Foster, E ;

Pellikka, PA ;

Picard, MH ;

Roman, MJ ;

Seward, J ;

Shanewise, JS ;

Solomon, SD ;

Spencer, KT ;

Sutton, MS ;

Stewart, WJ .

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2005, 18 (12) :1440-1463

[9] Clinical course of hypertrophic cardiomyopathy with survival to advanced age [J].

Maron, BJ ;

Casey, SA ;

Hauser, RG ;

Aeppli, DM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) :882-888

[10] Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy - A randomized, double-blind, crossover study (M-PATHY) [J].

Maron, BJ ;

Nishimura, RA ;

McKenna, WJ ;

Rakowski, H ;

Josephson, ME ;

Kieval, RS .

CIRCULATION, 1999, 99 (22) :2927-2933

← 1 2 3 →